Washington, D.C. – The results of the Spring 2020 BPS certification and recertification examinations were announced today by the Board of Pharmacy Specialties (BPS), the premier post-licensure certification organization serving the pharmacy profession. A total of 1,599 out of 2,340 candidates successfully passed certification and recertification examinations in the twelve specialties currently offered by BPS: Ambulatory Care Pharmacy, Cardiology Pharmacy, Compounded Sterile Preparations Pharmacy, Critical Care Pharmacy, Geriatric Pharmacy, Infectious Diseases Pharmacy, Nuclear Pharmacy, Nutrition Support Pharmacy, Oncology Pharmacy, Pediatric Pharmacy, Pharmacotherapy, and Psychiatric Pharmacy.
“Regardless of whether the candidate was successful in passing the examination or not, this continued interest in BPS Board Certification is a testament to the commitment those pharmacists demonstrate to provide high quality patient care,” stated BPS Executive Director, William M. Ellis, MS, RPh.
2020 BPS Chair, Karen Gunning, PharmD, BCPS, BCACP, stated, “BPS certification is my foundation; solid and enduring. Congratulations to those newly certified specialists, the achievement of this milestone demonstrates your professional emphasis on critical thinking and foundational patient care knowledge. By maintaining BPS Board certification, you will signal to all stakeholders that you stand prepared to provide the highest levels of patient care”
Spring 2020 Certification and Recertification examination results by specialty:
Specialty Initial Certification Recertification Board Certified Ambulatory Care Pharmacist (BCACP) 168 of 276 (61%) candidates 14 of 21 (67%) candidates Board Certified Cardiology Pharmacist (BCCP)* 38 of 59 (64%) candidates -- Board Certified Compounded Sterile Preparations Pharmacist (BCSCP)* 146 of 178 (82%) candidates -- Board Certified Critical Care Pharmacist (BCCCP)* 134 of 174 (77%) candidates -- Board Certified Geriatric Pharmacist (BCGP) 65 of 124 (52%) candidates 17 of 23 (74%) candidates Board Certified Infectious Diseases Pharmacist (BCIDP)* 92 of 135 (68%) candidates -- Board Certified Nuclear Pharmacist (BCNP) 1 of 2 (50%) candidates 1 of 2 (50%) candidates Board Certified Nutrition Support Pharmacist (BCNSP) 10 of 12 (83%) candidates 4 of 4 (100%) candidate Board Certified Oncology Pharmacist (BCOP) 101 of 172 (59%) candidates 16 of 23 (70%) candidates Board Certified Pediatric Pharmacy Specialist (BCPPS)* 56 of 85 (66%) candidates -- Board Certified Pharmacotherapy Specialist (BCPS) 655 of 940 (70%) candidates 50 of 61 (82%) candidates Board Certified Psychiatric Pharmacist (BCPP) 28 of 43 (65%) candidates 3 of 6 (50%) candidates
* The initial cohort of certificants in new specialty areas will be eligible to recertify by examination in year 7 of the certification cycle (i.e., BCCCP and BCPPS in 2022, BCCP and BCIDP in 2025, BCSCP in 2026).
Two examination windows are offered each year; in the spring and fall. Registration for the Fall 2020 examination are currently open and will close on August 3, 2020 and can be accessed at www.bpsweb.org.
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 46,000 pharmacist certifications across 14 specialties.
Social Media & Content Marketing Manager